Über den Kurs
This course covers all the scientific foundations needed to understand how Chimeric Antigen Receptor (CAR) T cells are engineered, their mechanism of action, the main challenges associated with CAR T cell therapies and the promises they hold for tomorrow's curative medicine.
This course also includes a first-in-class resource: Biotech Toolboxes. Biotech toolboxes offer different complementary ways to use relevant key terms, essential for mastering the common territory of all biotechnology. These terms constitute a growing Biotech Toolboxes Encyclopedia, a framework for the creation of shareable life sciences knowledge for all stakeholders in healthcare.
- All professionals involved in oncology drug development.
- All biomedical professionals in need of continuing medical education.
- Investors and other enablers of oncology drug pipelines.
- Regulatory affairs and regulatory science professionals.
- Cancer care providers and caregivers that are non-oncologists.
- University students interested in life sciences.
- Anyone with a strong interest in cancer therapies.
By the end of the course, you will have a clear conceptual understanding of:
- immunological cytotoxicity;
- the main classes of cytotoxic immune system cells;
- the notion of cancer immunosurveillance;
- MHC 1, T cell receptors and T cell cytotoxicity.
In addition, you will learn:
- how CAR T cells are engineered;
- how CAR T cell therapy is administered;
- what side effects it may have and how are these side effects managed;
- what are the limitations of current CAR T cell therapies;
- what may be future CAR T cell therapies and what diseases they may address.
- Unit 1 - Introduction
- Unit 2 - The Killer Cells within us
- Unit 3 - Immunosurveillance
- Unit 4 - The making of Serial Killers
- Unit 5 - The Kymriah Protocol
- Unit 6 - Side Effects
- Unit 7 - The Fantastic Voyages of the Future
Prior knowledge of basic cell biology and fundamentals of cancer biology recommended, but not required.
Our Video Partner
Special thanks to
Our Industry Partners
Verifizieren Sie Ihre aktive Kursteilnahme mit einem offiziellen Dokument